Skip to content

Psychedelic-assisted therapy: all studies

Page 145 of 294: studies 1,441 to 1,450 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

PHARMACOLOGICAL TREATMENT OF PTSD WITH PSYCHEDELICS: A FUTURE OUTLOOK

International Journal of Innovative Technologies in Social Science December 24, 2025 Michał Górski, Adam Januszkiewicz, Wiktoria Januszkiewicz et al.

Globally, approximately 3.9% of the population is estimated to experience Post Traumatic Stress Disorder during their lifetime. PTSD is characterized as a complex mental health condition that develops following exposure to traumatic events, manifesting through intrusive thoughts, hyperarousal, and avoidance behaviors. Despite psychotherapy and conventional pharmacotherapy being the standard...

DOI: 10.31435/ijitss.4(48).2025.4392 (opens in new tab) Traumatic stress Narrative review Mental health Population +10

A critical literature review of research on attachment and psychedelics: Synergies and research implications

Psychedelics December 23, 2025 Esenia K. Cassidy, Alan K. Davis, Smitha Rao

Attachment theory suggests that early-life interactions with caregivers define lifelong outcomes, including mental and physical health, problematic substance use, and well-being. However, little is known on how the resulting attachment orientations interact with outcomes of a novel treatment approach, psychedelic-assisted psychotherapies, or non-clinical psychedelic use. This critical...

DOI: 10.1016/j.psyche.2025.100007 (opens in new tab) Attachment theory Psychological intervention Positivism Mental health +6

A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants

medRxiv December 23, 2025 Chiranth Bhagavan, Olivia Carter, Glenn Nielsen et al. 1 citation preprint

Abstract Background Psychedelics exert widespread effects on brain activity, but their impact on motor function is unclear. This is clinically relevant given the emerging interest in psychedelic-assisted physical therapy for disorders of motor function. This study’s primary objectives examined the feasibility and safety of administering movement tasks following low-to-moderate doses of...

Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study

Psychedelic Medicine December 23, 2025 Anthony L. Back, Bonnie A. Mcgregor, Lindsay Billingsley et al. 1 citation

Background: Psilocybin therapy is an emerging treatment for cancer-related anxiety, depression, and existential distress. Most clinical trials to date have studied individual models of psilocybin therapy, but group models may offer increased access and benefits of community. Purpose: This technical report describes a group facilitation model developed for an food and drug administration...

“Tragic Person evolved: Transforming tragedy into hope through new, alternative treatments”

Psychoanalysis Self and Context December 22, 2025 Douglas Zimmerman

The paper, “Tragic Person Evolved: Transforming Tragedy Into Hope Through New, Alternative Treatments” was presented at the 45th IAPSP International Conference in Rome in October of 2024. The paper explores the integration of relational psychoanalysis and alternative treatments, including ketamine-assisted psychotherapy, for individuals with OCD, ADHD, and ASD. Two case studies illustrate how...

DOI: 10.1080/24720038.2025.2604803 (opens in new tab) Tragedy event Criticism Action physics Field mathematics +2

The genus Psilocybe in Italy

Italian Botanist December 22, 2025 Giuseppe Venturella, Manuela Rollini, Giulia Mirabile et al.

In the absence of specific studies on the Psilocybe genus in Italy, we provide information on the taxonomy, habitat, ecology, and distribution of the nine taxa currently recorded for Italy. A nomenclatural update of Psilocybe taxa reported in the Checklist of Italian Fungi (Basidiomycetes), published in 2005, is provided and seven scientific binomials are confirmed. In addition, P. medullosa...

The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.

Current Oncology December 22, 2025 Linda E. Carlson, Harriet Richardson, Ron Shore et al. 1 citation

The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) was launched in 2025 to address urgent gaps in supportive care for Canadians with cancer experiencing demoralization syndrome (loss of meaning, dysphoria, disheartenment, helplessness, a sense of failure) and related psychosocial distress. CAN-PACT has six major objectives: (1) to develop a national interdisciplinary...

Magic mushrooms and mood: exploring Psilocybin as a depression treatment

JPMA. The Journal of the Pakistan Medical Association December 20, 2025 Maria Rasool, Taha Hannan, Muhammad Imam

Dear Editor, In view of ongoing global research on mental health, especially Major Depressive Disorder, we would like to draw attention to a psychedelic substance, Psilocybin, which has been emerging as a viable treatment option for MDD. Psilocybin is a psychedelic compound derived from certain mushrooms that acts on Serotonergic receptors (primarily 5HT-2A). Psychedelic substances have...

Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development

Preprints.org December 19, 2025 Elena Koning, Susan Gamberg, Aaron Keshen preprint

Eating disorders (ED) remain challenging to treat, with high dropout and low remission rates in cognitive-behavioral therapy for EDs (CBT-ED). Psilocybin treatment (PT) demonstrates therapeutic potential to enhance CBT-ED by exerting several neurobiological, psychological, and experiential effects (e.g., antidepressant, neuroplasticity, emotional openness) that are hypothesized to increase...

Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice—Lessons Learned from a State Underrepresented in Clinical Psychedelic Research

Psychedelic Medicine December 19, 2025 Amanda Husein, Madalynn Traylor, M. Frances Vest et al.

Background: Psilocybin has been granted breakthrough therapy status in the United States, speeding its advancement from research to clinical care. Due to the controversial nature of psilocybin, psychiatrists may not be fully prepared to incorporate it into clinical practice. The current study aimed to evaluate the opinions toward psilocybin among practicing psychiatrists in Louisiana. Louisiana...